|
Market Closed -
Swiss Exchange
19:40:06 22/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.825 CHF | -1.21% |
|
-0.56% | +52.04% |
| Current month | -6.71% | ||
| 1 month | -3.26% |
Main features
| IE00BM8R0N95 | Fees | 0.5% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | CHF | AuM (AED) | 239.15M | Replication Method | Direct (Physical) |
| Number of securities | 49 | AuM evolution | - | Date of creation | 04/11/2021 |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | Developed markets |
| Theme and Sector | BioTech & Genomics |
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | CHF 9.825 | -1.21% | 0 |
| 21/10/26 | CHF 9.945 | +0.35% | 655 |
| 20/10/26 | CHF 9.910 | +3.50% | 0 |
| 19/10/26 | CHF 9.575 | -3.40% | 2 |
| 16/10/26 | CHF 9.912 | +0.32% | 1 |
- Stock Market
- ETF
- GNOM ETF
Select your edition
All financial news and data tailored to specific country editions





















